Capital Square 1031 Completes Diversified DST Offering of Nine Medical Office Buildings in Five States
RICHMOND, Va. (Nov. 1, 2018) – Capital Square 1031, a leading sponsor of Delaware statutory trust investments, announced today that CS1031 Diversified Dialysis Portfolio, DST, comprised of nine medical office buildings in five states, has been fully subscribed by a total of 45 investors.
Each property in the portfolio is 100 percent leased to Fresenius Medical Care, the world’s leading provider of dialysis services and products, on a long-term, net basis with annual CPI rental increases.
“Capital Square is pleased to fully subscribe this offering of our largest DST portfolio to-date, which provides investors the opportunity to own an interest in a high quality, diversified medical real estate portfolio in five states 100% leased to an investment-grade company. This offering is intended to provide stable cash flow from an investment-grade portfolio for 1031 exchange and other investors. By investing in a portfolio of necessity-based medical real estate, investors are able to reduce the risk they would face from a single asset investment,” said Louis Rogers, founder and chief executive officer of Capital Square 1031. The investment benefits from its need-based use – dialysis is a necessary and recurring medical treatment for more than 2.5 million Fresenius patients worldwide.”
Located in Texas, Tennessee, New York, Michigan and Mississippi, the portfolio includes the following properties:
• 5000 Campus Dr., a 10,640-square-foot building in Fort Worth, Texas,
• 9449 Grogans Mill Road, a 6,865-square-foot building in The Woodlands, Texas,
• 825-833 Dalworth St., a 9,150-square-foot building in Grand Prairie, Texas,
• 222 E. Sinton St., an 8,000-square-foot building in Sinton, Texas,
• 3600 Netherland Inn Road, a 7,028-square-foot building in Kingsport, Tennessee,
• 113 E. C Thurmond Cove, a 4,600-square-foot building in Martin, Tennessee,
• 220 Crystal Run Road, a 10,000-square-foot building in Middletown, New York,
• 5205 McAuley Dr., a 7,800-square-foot building in Ypsilanti, Michigan, and
• 241 Meadowlane St., a 3,215-square-foot building in Eupora, Mississippi.
Fresenius Medical Care Holdings, Inc. is a wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA (Fresenius), which is listed on both the Frankfurt Stock Exchange (FME) and New York Stock Exchange (FMS). The company is engaged in providing kidney dialysis services and clinical laboratory testing; manufacturing and distributing products and equipment for kidney dialysis treatment; and providing other medical ancillary services. During the 2017 fiscal year, Fresenius reported revenues of approximately $20 billion. The company cared for more than 325,000 dialysis patients in 3,815 proprietary clinics located in more than 45 countries worldwide. Also, Fresenius is the leading provider of dialysis products, including dialysis machines, dialyzers and disposable accessories.
Capital Square has acquired 70 properties for more than 1,300 investors seeking quality replacement properties that qualifies for tax deferral under Section 1031 of the Internal Revenue Code since its founding in fall 2012.
About Capital Square 1031
Capital Square 1031 is a national real estate investment and management company. The firm sponsors institutional-quality real estate exchange programs that qualify for tax deferral under Section 1031 of the Internal Revenue Code. Capital Square uses the Delaware Statutory Trust (DST) structure to make quality real estate available to a larger number of investors nationwide. Capital Square acquires multi-family properties for growth, necessary medical properties for stable income, and other real estate investments (sale lease-backs and purchases of headquarters, offices and facilities) that have the potential to provide exceptional risk adjusted returns. By acquiring a portfolio of DSTs, investors are able to diversify and reduce the risk they would face with a single asset investment. Capital Square aims to provide real estate investors greater access to quality investments and financial planning tools to better manage and mitigate risk.
Capital Square provides a range of services, including due diligence, acquisition, loan sourcing, property management/asset management, and disposition, for a growing number of high net worth investors, private equity firms, family offices and institutional investors. Since inception, the firm has sponsored 50 DSTs and has completed approximately $815 million in transaction volume. In August 2018, Capital Square ranked 1,613th on the Inc. 5000 list of fastest growing companies, with 288 percent three-year growth. In 2016, Capital Square was ranked as the second fastest growing company in the Richmond, Virginia area by Richmond BizSense. To learn more, visit www.CapitalSquare1031.com.